June 16, 2016
Salem, VA - June, 2016 – For the past 11 months, LewisGale Regional Cancer Center has undergone a multi-phase capital project, including $6.5 million in new radiation-therapy technology and renovations throughout the cancer center, including an expansive canopy entrance that leads patients and visitors into a spacious, welcoming reception area. The addition of new technology also includes a $2 million da Vinci Xi Surgical System and a $1 million 3D Mammography Unit. Also included is a $6 million two-story medical office building. To house the new radiation-delivering equipment, the construction required a new vault made with 3 million pounds of concrete, including 4-foot thick concrete walls.
“The additional space and renovations not only enhance the patient experience but will allow us to meet the growing demand for cancer services in our region,” said Mike Abbott, Chief Operating Officer, LewisGale Medical Center. “We’re also pleased to be the first health system in Southwest Virginia to offer this new technology to patients and the communities we serve. Each piece of technology will improve our ability to treat cancers faster and more precisely.”
The new technology includes a Varian TrueBeam Accelerator which increases the capability and capacity to treat patients in need of radiation therapy. Not only does it reduce patient treatment times, it delivers powerful cancer treatments with pinpoint accuracy by integrating new imaging and motion- management technologies. The system delivers many forms of radiotherapy treatment, including image- guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT) and RapidArc® radiotherapy technology.
The da Vinci Xi Surgical System has broader capabilities than prior generations of the da Vinci System. It can be used across a wide spectrum of minimally invasive surgical procedures and has been optimized for complex, multi-quadrant surgeries, as often required in cancer patients.
The Genius 3D Mammography detects 41% more invasive breast cancers and reduces false positives by up to 40% compared to traditional 2D images. The low-dose technology also eliminates the need for extra digital images and is particularly effective for women with dense breast tissue.
A new treatment planning system has also been added with upgraded quality assurance tools for enhanced monitoring and quality checks. The system, which can be accessed by physicians and technologists at both LewisGale Cancer Centers in Salem and Pulaski, provides the most seamless and effective treatment options available in our region to patients.